Mike Ward

Mike Ward joined Centrexion Therapeutics as CFO in 2019. He brings more than 25 years of experience, predominantly as an investment banker focused on life sciences and as both CFO and CBO of public and private life sciences companies. Prior to joining Centrexion, Mike served as CFO and CBO of Bionano Genomics, a NASDAQ-listed life sciences company. Prior to Bionano Genomics, Mike served as Executive Director of the Private Equity team of Lurie Investment Fund with a focus on life sciences investments. As an investment banker, Mike completed over 100 life sciences financings and M&A transactions (including nearly 20 IPOs) at Leerink Partners, Credit Suisse, BMO, Wasserstein, and Prudential Securities. Mike has also served on the board of directors of public and private life sciences companies, including Nanosphere, CytoPherx, Aperion Biologics and Impact Health. Mike graduated summa cum laude (highest distinction) from the University of Illinois in 1993 with a Bachelor of Science in Finance with a concentration in Accounting.